x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   After assembly poll results, Omar attacks arrogant Congress for ignoring realities | Democracy ends where J&K begins: Omar | ‘Kashmir based politicians want power back, forget statehood’ | Poll results show people stand with BJP’s politics of good governance: PM Modi | Govt committed to end all discrimination, create inclusive society: LG Sinha | MHA to meet agitating Ladakh groups today | Consider anyone coming to pick up drone-dropped weapons as nation’s biggest enemy: DGP Swain | Mughal Road reopens after 3 days closure | Gulmarg experiences season’s coldest night at -3.6-C | Birthday celebration of Bansi Lal Gupta at Green Belt Park Gandhi Nagar | Devotees gather for Maa Bhagwati’s Jagran in Jammu | 11-year fugitive apprehended by EOW CB Jammu: 19th successful arrest in 5 months | BJP’s 3-State Triumph sets stage for Modi-led futurep Predicts 2024 victory: Raman Suri | International Day of Persons with Disabilities observed in Samba | Sham Lal Sharma calls for swift action on pending disability demands | Reinforcement of spirituality in lifestyle interventions need of hour: Dr Sushil | Stage set for stormy winter session of Parliament | Woman’s boyfriend held for murdering her husband in Sopore: Police | Kavinder Gupta attributes BJP’s success in assembly polls to phenomenal victory in 2024 | Assembly poll results show ‘Modi magic’ remains strong in Hindi heartland | BSF celebrates 59th Raising Day at frontier headquarter in Srinagar | Side with weaker population | Back Issues  
 
news details
Serum Institute seeks inclusion of Covid Jab 'Covovax' in CoWIN portal
1/18/2023 10:48:02 PM
agencies
NEW DELHI, Jan 18: Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
The letter was written by Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), they said.
National Technical Advisory Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter.
The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two doses of either Covishield or Covaxin.
Its approval was based on recommendations by the subject expert committee (SEC) of the Central Drugs Standard Control Organisation.
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and also in children aged seven to 11 years on June 28 last year subject to certain conditions
Covovax is manufactured through technology transfer from Novavax.
It has been approved by the European Medicines Agency for conditional marketing authorization and was granted emergency-use listing by the World Health Organization (WHO) on December 17, 2021.
In August 2020, US-based vaccine maker Novavax Inc. had earlier announced a license agreement with the SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate in India and low-and-middle-income countries.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU